Assessment of effect of irbesartan and nebivolol on the left atrium volume and deformation in the patients with mild-moderate hypertension

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 6, 2014, Pages 781-789

  Degirmenci, H ^a   Duman, H ^b   Demirelli, S ^c   Bakirci, E M ^a   Hamur, H ^a   Inci, S ^d   Simsek, Z ^e   Askin, L ^e   Arisoy, A ^c   Lazoglu, Z ^e  

^a ERZINCAN UNIVERSITY   (Turkey)

^b Rize Devlet Hastanesi   (Turkey)

^c Department of Cardiology Erzurum Education and Research Hospital ^*  (Turkey)

^d Aksaray State Hospital   (Turkey)

^e ATATURK UNIVERSITY   (Turkey)

Author keywords

Irbesartan; Left atrial function; Nebivolol

Indexed keywords

ANTIHYPERTENSIVE AGENT; IRBESARTAN; NEBIVOLOL; BENZOPYRAN DERIVATIVE; BIPHENYL DERIVATIVE; ETHANOLAMINE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG EFFICACY; ECHOCARDIOGRAPH; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT ATRIUM; HEART LEFT ATRIUM GLOBAL PEAK SYSTOLIC STRAIN; HEART LEFT ATRIUM GLOBAL PEAK SYSTOLIC STRAIN RATE; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE CONTRACTION; HEART PERFORMANCE; HEART VOLUME; HUMAN; HYPERTENSION; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; ULTRASOUND TRANSDUCER; BLOOD PRESSURE; DRUG EFFECTS; HEART ATRIUM; PROCEDURES; SYSTOLE;

ANTIHYPERTENSIVE AGENTS; BENZOPYRANS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; DIASTOLE; ECHOCARDIOGRAPHY; ETHANOLAMINES; FEMALE; HEART ATRIA; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SYSTOLE; TETRAZOLES;

EID: 84902106827     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. MATSUDA M, MATSUDA Y. Mechanism of left atrial enlargement related to ventricular diastolic impairment in hypertension. Clin Cardiol 1996; 19: 954-959.
2. DRESLINSKI GR, FROHLICH ED, DUNN FG, MESSERLI FH, SUAREZ DH, REISIN E. Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index. Am J Cardiol 1981; 47: 1087-1090.
3. VERDECCHIA P, REBOLDI G, GATTOBIGIO R, BENTIVOGLIO M, BORGIONI C, ANGELI F, CARLUCCIO E, SARDONE MG, PORCELLATI C. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003; 41: 218-223.
4. YAMAGUCHI H, YOSHIDA J, YAMAMOTO K, SAKATA Y, MANO T, AKEHI N, HORI M, LIM YJ, MISHIMA M, MASUYAMA T. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004; 43: 55-60.
5. TSANG TS, BARNES ME, GERSH BJ, BAILEY KR, SEWARD JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90: 1284-1289.
6. CUSPIDI C, MEANI S, FUSI V, VALERIO C, CATINI E, SALA C SAMPIERI L, MAGRINI F, ZANCHETTI A. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension Study. J Hypertens 2005; 4: 875-882.
7. GERDTS E, OIKARINEN L, PALMIERI V, OTTERSTAD J, WACHTELL K, BOMAN K, DAHLF B, DEVEREUX RB. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study. Hypertension 2002; 39: 739-743.
8. MILLER JT, O'ROURKE RA, CRAWFORD MH. Left atrial enlargement: an early sign of hypertensive heart disease. Am Heart J 1988; 116: 1048-1451.
9. PAVLOPOULOS H, NIHOYANNOPOULOS P. Strain and strain rate deformation parameters: from tissue Doppler to 2D speckle tracking. Int J Cardiovasc Imaging 2008; 5: 479-991.
10. GUIDELINES COMMITTEE 2007. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1106-1187.
11. LANG RM, BIERIG M, DEVEREUX RB, FLACHSKAMPF FA, FOSTER E, PELLIKKA PA, PICARD MH, ROMAN MJ, SEWARD J, SHANEWISE J, SOLOMON S, SPENCER KT, ST JOHN SUTTON M, STEWART W. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
12. LUMINITA LATEA, STEFANIA L. NEGREA, SORANA D. BOLBOACA. Effects of valsartan and nebivolol on blood pressure, QT dispersion and left ventricular hypertrophy in hypertensive patients. Dicle Med J 2010; 37(Suppl 2): 81-88.
13. SAHANA GN, SARALA N, KUMAR TN, LAKSHMAIAH V. A comparative study of nebivolol and atenolol on blood pressure and heart rate on essential hypertensive patients. Indian J Pharmacol 2010; 42: 401-405.
14. VITALE C, MARAZZI G, IELLAMO F, SPOLETINI I, DALL'AMI V, FINI M, VOLTERRANI M. Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: The NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study. Int J Cardiol 2011; Nov 9.
15. MORSING P, ADLER G, BRANDT-ELIASSON U, KARP L, OHLSON K, RENBERG L. Mechanistic differences of various AT-1 receptor blockers in isolated vessels of different origin. Hypertension 1999; 33: 1406-1413.
16. PRITCHETT AM, JACOBSEN SJ, MAHONEY DW, RODEHEFFER RJ, BAILEY KR, REDFIELD MM. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 2003; 41: 1036-1043.
17. CIOFFI G, MUREDDU GF, STEFENELLI C. Influence of age on the relationship between left atrial performance and left ventricular systolic and diastolic function in systemic arterial hypertension. Exp Clin Cardol 2006; 11: 305-310.
18. SUZANNE ESHOO, DAVID L. Ross and Liza Thomas. Impact of Mild Hypertension on Left Atrial Size and Function. Circ Cardiovasc Imaging 2009; 2: 93-99.
19. MATTIOLI AV, BONATTI S, MONOPOLI D, ZENNARO M, MATTIOLI G. Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension. Blood Pressure 2005; 14: 273-278.
20. KOKUBU N, YUDA S, TSUCHIHASHI K, HASHIMOTO A, NAKATA T, MIURA T, URA N, NAGAO K, TSUZUKI M, WAKABAYASHI C, SHIMAMOTO K. Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of renin-angiotensin system inhibition on left atrial function. Hypertens Res 2007; 30: 13-21.
21. MOTTRAM PM, HALUSKA B, LEANO R, COWLEY D, STOWASSER M, MARWICK TH. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 2004; 110: 558-565.
22. INABA Y, YUDA S, KOBAYASHI N, HASHIMOTO A, UNO K, NAKATA T, TSUCHIHASHI K, MIURA T, URA N, SHIMAMOTO K. Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation. J Am Soc Echocardiogr 2005; 18: 729-736.